343 related articles for article (PubMed ID: 18512024)
1. Cancer stem cells as targets for cancer therapy: selected cancers as examples.
Hombach-Klonisch S; Paranjothy T; Wiechec E; Pocar P; Mustafa T; Seifert A; Zahl C; Gerlach KL; Biermann K; Steger K; Hoang-Vu C; Schulze-Osthoff K; Los M
Arch Immunol Ther Exp (Warsz); 2008; 56(3):165-80. PubMed ID: 18512024
[TBL] [Abstract][Full Text] [Related]
2. Current understanding of cancer stem cells: Review of their radiobiology and role in head and neck cancers.
Reid PA; Wilson P; Li Y; Marcu LG; Bezak E
Head Neck; 2017 Sep; 39(9):1920-1932. PubMed ID: 28644558
[TBL] [Abstract][Full Text] [Related]
3. Cancer stem cells and stemness markers in oral squamous cell carcinomas.
Patel SS; Shah KA; Shah MJ; Kothari KC; Rawal RM
Asian Pac J Cancer Prev; 2014; 15(20):8549-56. PubMed ID: 25374166
[TBL] [Abstract][Full Text] [Related]
4. The role of BMI1 as a biomarker of cancer stem cells in head and neck cancer: a review.
Allegra E; Trapasso S; Pisani D; Puzzo L
Oncology; 2014; 86(4):199-205. PubMed ID: 24800958
[TBL] [Abstract][Full Text] [Related]
5. Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma.
Habu N; Imanishi Y; Kameyama K; Shimoda M; Tokumaru Y; Sakamoto K; Fujii R; Shigetomi S; Otsuka K; Sato Y; Watanabe Y; Ozawa H; Tomita T; Fujii M; Ogawa K
BMC Cancer; 2015 Oct; 15():730. PubMed ID: 26483189
[TBL] [Abstract][Full Text] [Related]
6. [Biology and relevance of stem cells in squamous head and neck cancer: latest insights and review of literature].
Oker N; Kaufmann AM; Albers AE
Laryngorhinootologie; 2012 May; 91(5):326-32; quiz 333-4. PubMed ID: 22517584
[TBL] [Abstract][Full Text] [Related]
7. Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4.
Lee SH; Koo BS; Kim JM; Huang S; Rho YS; Bae WJ; Kang HJ; Kim YS; Moon JH; Lim YC
J Pathol; 2014 Sep; 234(1):99-107. PubMed ID: 24871033
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro.
Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE
Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head-neck cancer.
Koukourakis MI; Giatromanolaki A; Tsakmaki V; Danielidis V; Sivridis E
Br J Cancer; 2012 Feb; 106(5):846-53. PubMed ID: 22333601
[TBL] [Abstract][Full Text] [Related]
10. Cancer stem cells - new and potentially important targets for the therapy of oral squamous cell carcinoma.
Costea DE; Tsinkalovsky O; Vintermyr OK; Johannessen AC; Mackenzie IC
Oral Dis; 2006 Sep; 12(5):443-54. PubMed ID: 16910914
[TBL] [Abstract][Full Text] [Related]
11. CD166 promotes the cancer stem-like properties of primary epithelial ovarian cancer cells.
Kim DK; Ham MH; Lee SY; Shin MJ; Kim YE; Song P; Suh DS; Kim JH
BMB Rep; 2020 Dec; 53(12):622-627. PubMed ID: 32843129
[TBL] [Abstract][Full Text] [Related]
12. A novel reporter construct for screening small molecule inhibitors that specifically target self-renewing cancer cells.
Shanmugam G; Mohan A; Kumari K; Louis JM; Soumya Krishnan U; Balagopal PG; George NA; Sebastian P; Maliekal TT
Exp Cell Res; 2019 Oct; 383(2):111551. PubMed ID: 31401066
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cells: mediators of tumorigenesis and metastasis in head and neck squamous cell carcinoma.
Chinn SB; Darr OA; Owen JH; Bellile E; McHugh JB; Spector ME; Papagerakis SM; Chepeha DB; Bradford CR; Carey TE; Prince ME
Head Neck; 2015 Mar; 37(3):317-26. PubMed ID: 24415402
[TBL] [Abstract][Full Text] [Related]
14. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
Bourguignon LYW; Earle C; Shiina M
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
[TBL] [Abstract][Full Text] [Related]
15. Biology and immunology of cancer stem(-like) cells in head and neck cancer.
Qian X; Ma C; Nie X; Lu J; Lenarz M; Kaufmann AM; Albers AE
Crit Rev Oncol Hematol; 2015 Sep; 95(3):337-45. PubMed ID: 25907739
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of non-coding RNAs as potential targets in head and neck squamous cell carcinoma cancer stem cells.
Rahimy E; Kuo SZ; Ongkeko WM
Curr Drug Targets; 2014; 15(13):1247-60. PubMed ID: 25341422
[TBL] [Abstract][Full Text] [Related]
17. Plasma membrane proteomics of tumor spheres identify CD166 as a novel marker for cancer stem-like cells in head and neck squamous cell carcinoma.
Yan M; Yang X; Wang L; Clark D; Zuo H; Ye D; Chen W; Zhang P
Mol Cell Proteomics; 2013 Nov; 12(11):3271-84. PubMed ID: 23903875
[TBL] [Abstract][Full Text] [Related]
18. Targeting cancer stem cell plasticity through modulation of epidermal growth factor and insulin-like growth factor receptor signaling in head and neck squamous cell cancer.
Leong HS; Chong FT; Sew PH; Lau DP; Wong BH; Teh BT; Tan DS; Iyer NG
Stem Cells Transl Med; 2014 Sep; 3(9):1055-65. PubMed ID: 25024430
[TBL] [Abstract][Full Text] [Related]
19. Head and Neck Cancer Stem Cells: From Identification to Tumor Immune Network.
Dionne LK; Driver ER; Wang XJ
J Dent Res; 2015 Nov; 94(11):1524-31. PubMed ID: 26253189
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
Bourguignon LY; Wong G; Earle C; Chen L
J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
